Mergers & Acquisitions

  • February 12, 2024

    Alys Pharmaceuticals Launches With $100M In Financing

    A new immuno-dermatology company created as an amalgamation of six separate startups launched on Monday with $100 million in financing to target dermatological indications.

  • February 12, 2024

    Kodiak Gas Gives Enforcers More Time To Review $854M Deal

    Kodiak has given enforcers more time to review its planned $854 million deal for CSI Compressco, which would combine two major providers of compression services to the oil and gas industry.

  • February 12, 2024

    Oil Driller Accused Of Using Creditor Assets For Ch. 11

    A group of claimants in a Texas-based oil driller's Chapter 11 case recently asked a bankruptcy judge to reject the debtor's proposal for reorganization, alleging the plan would unlawfully use their property interests to pay off the company's debts and administrative costs.

  • February 12, 2024

    Musk Can't Dodge SEC Questions About $44B Twitter Buy

    A California federal judge has told Elon Musk that he must appear before the U.S. Securities and Exchange Commission to testify about his $44 billion purchase of the social media platform formerly known as Twitter, waving off the billionaire's assertions that the agency was harassing him via a series of seemingly endless investigations.

  • February 12, 2024

    Cannabis Fintech Withheld $500K In $7.5M Deal, Suit Says

    A Washington state-based fintech firm that provides payment solutions to cannabis retailers failed to pay the final $500,000 in a $7.5 million deal to buy a rival company, according to a breach-of-contract suit filed in Seattle federal court.

  • February 12, 2024

    Frank Execs Say JPMorgan Is Withholding Communications

    Charlie Javice and Olivier Amar, the indicted former executives of student loan startup Frank, asked a Manhattan federal judge Saturday for an extension of time to decide on raising an advice-of-counsel defense at their trial, saying they can't make a decision yet because JPMorgan is withholding discovery of their communications with Frank's general counsel.

  • February 12, 2024

    Online Marketplace Wish Sold At Steep Discount To $1.1B IPO

    ContextLogic Inc. announced Monday that it would sell off its operating assets and liabilities, including the e-commerce platform Wish, to Qoo10 for $173 million, in a deal that represents a significant drop-off from Wish's $1.1 billion initial public offering in 2020 and that was driven by respective legal advisers Sidley Austin LLP and Shearman & Sterling LLP.

  • February 12, 2024

    Tod's Stock Rises After Go-Private Takeover Bid Disclosed

    Italian luxury shoe and apparel manufacturer Tod's Group experienced a more than 18% stock bump Monday after disclosing a go-private offer from private equity firm L Catterton valued at €43 ($46.36) per share.

  • February 12, 2024

    Viking Energy Shareholder Says Merger Was For CEO's Gain

    The former CEO of Texas energy company Viking Energy Group Inc. has been slapped with a proposed shareholder class action claiming he pursued a merger with a "financially troubled" shell company in order to provide himself with an exponentially greater claim of Viking's economic value.

  • February 12, 2024

    AI Cybersecurity Biz Secures $102M Of VC-Led Financing

    Information technology security company Bugcrowd announced Monday that it secured a $102 million investment to grow its crowdsourced, artificial intelligence-powered security platform offerings globally.

  • February 12, 2024

    Mergers & Acquisitions Group Of The Year: Cravath

    Cravath Swaine & Moore LLP guided the Snyder family through a tense environment to seal the $6.05 billion sale of the Washington Commanders and advised WestRock's complicated $20 billion combination with Smurfit Kappa, earning the firm a spot among Law360's 2023 Mergers and Acquisitions Groups of the Year.

  • February 12, 2024

    Gilead Buying Liver Disease Drugmaker CymaBay For $4.3B

    Gilead Sciences Inc. said Monday that it has agreed to purchase liver disease-focused clinical-stage biopharmaceutical company CymaBay Therapeutics Inc. for $4.3 billion in cash.

  • February 12, 2024

    Hogan Lovells Builds Out Corp. Group With 2 Partners

    Hogan Lovells announced Monday it has bolstered its corporate and finance group with the hiring of new partners in New York and Boston.

  • February 12, 2024

    Martin Marietta Paying $2B For Blue Water Raw Materials Ops

    Cravath-advised building materials supplier Martin Marietta Materials Inc. said Monday it has agreed to buy 20 active aggregate operations across five states from Blue Water Industries LLC, represented by Wachtell Lipton, for $2.05 billion in cash. 

  • February 12, 2024

    Diamondback Buying Endeavor In $26B Permian Megamerger

    Diamondback Energy Inc. said Monday it has agreed to buy Endeavor Energy Resources LP in a cash-and-stock deal valued at approximately $26 billion, inclusive of Endeavor's net debt, to create the premier independent operator in the Permian Basin.

  • February 12, 2024

    French Music Label Tunes In To €1.5B Bid From Founder

    French digital music label Believe SA said Monday that it has been handed a €1.46 billion ($1.57 billion) offer by an investment consortium that includes its founder to take the company off the French stock exchange.

  • February 09, 2024

    No More Shady Trading For Ex-FBI Trainee After BigLaw Theft

    The former FBI trainee who secretly traded nonpublic information that he stole from his BigLaw associate ex-girlfriend has agreed to a civil judgment against him permanently barring him from violating securities laws, a judgment entered just months after he pled guilty to insider trading.

  • February 09, 2024

    Rite Aid Investors' Attys Get $58M As Walgreens Deal OK'd

    Counsel representing a class of Rite Aid investors will take home nearly $58 million in attorney fees after a Pennsylvania federal judge granted final approval to the $192.5 million deal resolving claims that Walgreens' executives lied about the likelihood of an ultimately unsuccessful merger between the two drugstore chains.

  • February 09, 2024

    Live Nation Defends 'Modest' Arbitration Tweaks At 9th Circ

    Live Nation Entertainment Inc. told the Ninth Circuit that a California district judge was wrong to remove ticket buyers' antitrust claims from arbitration simply because the company changed arbitrators.

  • February 09, 2024

    Labaton, Rolnick Clash Over Legal Fees In Materials Co. Deal

    Law-firm battling has sharpened over multimillion-dollar legal fee claims linked to a proposed $19 million Delaware Court of Chancery settlement for a stockholder suit challenging a $3.1 billion materials company sale in 2019, court records show.

  • February 09, 2024

    Healthcare-Focused SPAC Hits The Market After $160M IPO

    Blank-check company Helix Acquisition Corp. II hit the public markets on Friday following its upsized initial public offering, which raised $160 million by offering 16 million shares at a price of $10 apiece.

  • February 09, 2024

    Activist Says CEO's Family Is Problem For Chef's Warehouse

    Specialty foods company The Chef's Warehouse has become the latest target of activist investor Legion Partners, which is asking the company's shareholders to nominate four new board members to turn around "chronic underperformance" stemming from the board's family connections.

  • February 09, 2024

    FTC Clears AbbVie To Proceed With $10.1B ImmunoGen Buy

    The 30-day waiting period for U.S. antitrust enforcers to review AbbVie's $10.1 billion purchase of ImmunoGen came and went without a move to deepen the investigation or challenge the deal, clearing the parties to close the agreement on or about Monday, ImmunoGen said on Thursday.

  • February 09, 2024

    Audacy Floats Two Ch. 11 Sales That Could Net Debtor $21.6M

    Bankrupt radio station operator Audacy Inc. wants to sell two pieces of real estate near Boston for as much as $21.6 million to raise funds for its estate in Chapter 11, asking a Texas judge to approve the deals so that it can close on them by early March.

  • February 09, 2024

    Eargo Investors Sue In Del. For Patient Square Merger Docs

    Two shareholders of California medical device company Eargo Inc. sued in Delaware's Court of Chancery on Thursday, seeking books and records to investigate potential wrongdoing and breaches of fiduciary duties in connection with a pending buyout by controlling shareholder Patient Square Capital LP.

Expert Analysis

  • Looking For Plausibility In FTC's Amgen Merger Challenge

    Author Photo

    The Federal Trade Commission is seeking to block Amgen's acquisition of Horizon, alleging that, if consummated, the deal would violate Section 7 of the Clayton Act — but this may be the first merger complaint in a generation that could be dismissed for failing to state a claim, say William MacLeod and David Evans at Kelley Drye.

  • Some Client Speculations On AI And The Law Firm Biz Model

    Author Photo

    Generative artificial intelligence technologies will put pressure on the business of law as it is structured currently, but clients may end up with more price certainty for legal services, and lawyers may spend more time being lawyers, says Jonathan Cole at Melody Capital.

  • Private Equity Firms Shouldn't Overlook Cybersecurity Risks

    Author Photo

    Given the operational, financial and reputational costs at stake, and the growing threat of cybercrime, cybersecurity should be central to deal making, internal governance and post-acquisition management for private equity firms, say Ray Bogenrief and William Ridgway at Skadden.

  • A Look At Texas Business Courts' Potential M&A Impact

    Author Photo

    A bill heading to Texas Gov. Greg Abbott's desk is a push for specialist judges with more expertise in the business area, but it is unlikely to have an immediate effect on mergers and acquisition practitioners and contracts, for several important reasons, says Candace Groth at Vela Wood.

  • Assessing Overlapping Boards After DOJ Crackdown

    Author Photo

    The U.S. Department of Justice’s recent targeting of interlocking directorates raises questions about the scope of applicable antitrust law, including when companies will be considered competitors, whether the statute reaches potential competitors, and how companies can avoid price-fixing or market allocation charges, say attorneys at Cooley.

  • Environmental Diligence Is Crucial When Buying Biofuel Cos.

    Author Photo

    As momentum for mergers and acquisitions transactions within the biofuels industry continues to grow, potential buyers must not neglect proper diligence and thoughtful negotiation regarding environmental attributes generated in connection with the target's products and production process, says Victoria Sitz at Husch Blackwell.

  • Lessons On Corporate Fiduciary Duties From Del. M&A Case

    Author Photo

    The recent decision in New Enterprise Associates v. Rich, which held that a contractual covenant by certain stockholders not to challenge specific sales of the company was enforceable, highlights that the Delaware Court of Chancery generally is likely to be receptive to waivers of fiduciary duties that are agreed by sophisticated stockholders, say attorneys at Fried Frank.

  • Failed Tegna Deal Reveals Increasing Merger Review Hurdles

    Author Photo

    A deeper look at how the Tegna-Standard General deal derailed during merger review suggests some practical steps that firms should consider to close transactions when dealing with multiple federal agencies operating under a whole-of-government antitrust enforcement approach, say Jody Boudreault and Katherine Dutcher at Baker Botts.

  • A Lawyer's Guide To Approaching Digital Assets In Discovery

    Author Photo

    The booming growth of cryptocurrency and non-fungible tokens has made digital assets relevant in many legal disputes but also poses several challenges for discovery, so lawyers must garner an understanding of the technology behind these assets, the way they function, and how they're held, says Brett Sager at Ehrenstein Sager.

  • Opinion

    High Court's Ethics Statement Places Justices Above The Law

    Author Photo

    The U.S. Supreme Court justices' disappointing statement on the court's ethics principles and practices reveals that not only are they satisfied with a status quo in which they are bound by fewer ethics rules than other federal judges, but also that they've twisted the few rules that do apply to them, says David Janovsky at the Project on Government Oversight.

  • A Look At Corwin Cleansing After Chancery Edgio Ruling

    Author Photo

    The Delaware Chancery Court's denial of Corwin cleansing in an action seeking post-closing injunctive relief in the Edgio stockholders case has potentially significant implications for corporations and their boards in the negotiation of investment agreements with significant stockholders, say attorneys at Cleary.

  • Opinion

    Time For Law Schools To Rethink Unsung Role Of Adjuncts

    Author Photo

    As law schools prepare for the fall 2023 semester, administrators should reevaluate the role of the underappreciated, indispensable adjunct, and consider 16 concrete actions to improve the adjuncts' teaching experience, overall happiness and feeling of belonging, say T. Markus Funk at Perkins Coie, Andrew Boutros at Dechert and Eugene Volokh at UCLA.

  • 4 Areas Of Heightened Antitrust Risk In Private Equity

    Author Photo

    Antitrust enforcement and litigation are moving from portfolio companies to the private equity firms that invest in them, and a few areas of elevated risk stand out, say Ann O’Brien and Lindsey Collins at Sheppard Mullin.

  • Courthouse Door Now Open To FERC Enforcement Challenges

    Author Photo

    The U.S. Supreme Court's recent ruling in U.S. Securities and Exchange Commission v. Cochran and Axon v. Federal Trade Commission is also relevant to some Federal Energy Regulatory Commission enforcement processes — meaning many entities regulated by FERC can now more easily challenge commission proceedings in court, say Todd Mullins and Emily Song at McGuireWoods.

  • Tips For In-House Legal Leaders In A Challenging Economy

    Author Photo

    Amid today's economic and geopolitical uncertainty, in-house legal teams are running lean and facing increased scrutiny and unique issues, but can step up and find innovative ways to manage outcomes and capitalize on good business opportunities, says Tim Parilla at LinkSquares.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!